Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Cancer Research|December 17, 2005
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesotheliomaArminder S Jassar, Eiji Suzuki, Veena Kapoor, et al.
Cancer Research|October 8, 2010
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumorYangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
The Annals of Thoracic Surgery|August 10, 2014
Intraoperative near-infrared imaging can identify pulmonary nodulesOlugbenga T Okusanya, David Holt, Daniel Heitjan, et al.
Molecular Cancer Therapeutics|August 13, 2009
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancerM Cecilia Crisanti, Africa F Wallace, Veena Kapoor, et al.
Cancer Research|December 24, 2009
CCL2 blockade augments cancer immunotherapyZvi G Fridlender, George Buchlis, Veena Kapoor, et al.
Annals of Surgery|September 15, 2015
The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary AdenocarcinomasGregory T Kennedy, Olugbenga T Okusanya, Jane J Keating, et al.
Plos One|September 27, 2008
Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cellsRichard G Carroll, Carmine Carpenito, Xiaochuan Shan, et al.
Cancer Research|December 17, 2008
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapySamuel Kim, George Buchlis, Zvi G Fridlender, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2011
Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicityLiang-Chuan S Wang, Rachel C Lynn, Guanjun Cheng, et al.
Oncoimmunology|March 5, 2016
CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesisYuhong Liu, Claire E O'Leary, Liang-Chuan S Wang, et al.
Pageof 23